Sentences with phrase «bacteria in my lungs»

Over time, bacteria in the lungs can become resistant to antibiotics making it increasingly difficult to treat lung infections and leading to irreversible damage to the lungs.

Lungs Newborns with certain types of bacteria in their lungs are more likely to develop asthma.

Mice treated with the combination had almost 40,000 times fewer bacteria in their lungs.

Substances produced by a harmful bacterium in the lungs of cystic fibrosis patients may enhance the growth of other bacteria that, in turn, inhibit the harmful bacterium's biofilm, according to new research published in PLOS Pathogens.

Substances produced by a harmful bacterium in the lungs of cystic fibrosis patients may enhance the growth of other bacteria that, in turn, inhibit the harmful bacterium's biofilm, according to new research.

«Infections with progressively resistant bacteria in the lung shorten the lives of people with cystic fibrosis,» said Joseph M. Pilewski, M.D., co-director of the Adult Cystic Fibrosis Center at UPMC.

The researchers next showed that the Smurf1 gene controls M. tuberculosis growth in human macrophages and that the Smurf1 protein was found in association with bacteria in the lungs of patients with tuberculosis infections.

In multiple trials of mice with both active and chronic TB infections, researchers report that one version of the new drug — an analog known as 1599 — was as good as or better than current TB drugs at reducing levels of the bacteria in the lungs of mice.

To measure the differences in immune system function between the two groups of older mice, the researchers examined the lungs to assess damage, counted the number of bacteria in the lungs, and calculated the number of the white blood cells (neutrophils).

In the past, researchers studied Pseudomonas in isolation despite the fact that it's rarely the lone bacterium in the lungs of people with CF. Hoffman decided to study how Pseudomonas and Staphylococcus aureus — the other bacterium most commonly found in the lungs of cystic fibrosis patients — behave when the two are grown together.

***** Extra Vitamin E Protected Older Mice from Getting Common Type of Pneumonia http://now.tufts.edu/news-releases/extra-vitamin-e-protected-older-mice-getting-common-type-pneumonia «-- 1,000 times fewer bacteria in their lungs» ****** These vitamins can work synergistically: Synergistic interactions between vitamin A and vitamin E against lipid peroxidation in phosphatidylcholine liposomes.

After a lengthy recovery after spinal surgery and fighting bacteria in my lungs I discovered painting as a form of therapy!

Not exact matches

Mycoplasma pneumoniae is a bacteria that can cause mild infections in the lung.

Examples I personally can document: a plague of deadly bacteria in the newborn nursery killing 3 previously healthy newborns, exploding the fetal lungs with too forceful dose of oxygen after birth by inexperienced doctor, crushing the skull during forceps extraction, overdose of adrenalin to newborn by a nurse, slow paging or slow response to call to resuscitate newborn, exploding the uterus (uterine rupture) and / or placental abruption as a result of high IV dose of oxytocin in labor in a low risk women.

Predatory bacteria attenuate Klebsiella penumoniae burden in rat lungs.

Joint first author of the study, microbiologist Dr Jo Fothergill said: «We have discovered that the nasopharynx acts as a silent reservoir for bacteria from which more serious infections in the lungs can develop.»

Despite the presumed virulence of the strain — experiments with mouse lungs showed it produces 1000 times more bacteria in infected cells than do standard varieties — Valway says the number of TB cases that developed were kept in line with other typical outbreaks, which «shows that doing good contact investigations is important and preventative therapy works.»

The scientists tested the new compound using a mouse model of TB and found that substituting R207910 for one of three antibiotics in a treatment cocktail significantly reduced the time required to clear the animals» lungs of bacteria.

The bacteria, Burkholderia cenocepacia, are highly antibiotic resistant and cause severe lung infections in people with cystic fibrosis.

After «inhaling» E. coli, for instance, the lung attracted human white blood cells to attack and kill the bacteria, a process scientists have long understood but never before witnessed in vitro.

Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90 % disease control and 59 % response rate in patients with malignant pleural mesothelioma (MPM), according to the results of a phase Ib trial presented today at the European Lung Cancer Conference (ELCC) 2016 in Geneva, Switzerland.1

Image courtesy of iStockphoto / kajakiki Bacteria hiding in the lungs might not be able to hide much longer.

«Because the bacterium that causes TB can lie dormant in someone's lung for months or even years before it causes disease, we had no way of knowing whether a TB case we have just diagnosed was a recent infection — suggesting the outbreak is still going on — or whether the person was infected years ago.»

Unbeknownst to Knight's team at the time, the infant staying in that room had had a lung infection with that bacterium.

«This is critical in removing bacteria from sequestered spaces in the lung,» he says.

The team has now also tested the bacteria on a woman with tumours in her liver, lungs and soft tissue that didn't respond to standard treatment.

In cystic fibrosis, a serious genetic disease that causes recurring lung infections, bacteria colonize a patient's lungs, usually beginning in childhood, leading to difficulty breathinIn cystic fibrosis, a serious genetic disease that causes recurring lung infections, bacteria colonize a patient's lungs, usually beginning in childhood, leading to difficulty breathinin childhood, leading to difficulty breathing.

Three days later, the scientists discovered that although the mice had cleared the bacteria from their livers, lungs, and spleens, the tumorous tissue in their colons was crawling with Salmonella.

Others note that the ability to re-create conditions closer to the sputum in the lung of a CF patient will lead to better understanding of how different strains of the bacterium behave.

They reprogrammed E. coli to sense Pseudomonas aeruginosa — a bacteria that can form biofilms and causes hospital - acquired infections in the lungs and the gut.

One of the most dangerous of these bacteria is P. aeruginosa, which, within the unique mucus that forms in the lungs of a person with cystic fibrosis, develops into large, antibiotic - resistant colonies.

Marvin Whiteley, a professor of molecular biosciences, and his research team at The University of Texas at Austin explain in the paper how they applied new technology to bacteria thriving in actual samples of the mucus from CF lungs to model the behavior of the bacterium in that environment.

Experiments that model the bacteria in animal cells, for example, have shown that P. aeruginosa behaves and grows in certain ways only when it is in the infected lungs of a person with CF.

The researchers» report appears in the journal ACS Synthetic Biology and describes development of this new type of E. coli that can even kill off slimy groups of bacteria called biofilms that are responsible for many hard - to - treat infections, such as those that take hold in the lungs, the bladder and on implanted medical devices.

By using molecular genetic tools to reduce the amount of PC in human lung cancer cells, the team observed decreased cell growth, a compromised ability to form colonies in soft agar (a gelatinous material specifically used to grow bacteria and other cells), and a reduced rate of tumor growth in mice.

These opportunistic bacteria can grow on hospital surfaces or in lungs and tissues.

These proteins aid in marking bacteria invading the lung for destruction by the immune system.

The researchers also checked for the bacteria in two lung transplant recipients who had hyperammonemia but were still alive.

Instead, they detected a different bacterium, Ureaplasma urealyticum, in the man's blood and in samples from his bladder, spleen, liver, and lungs.

In less than five minutes, Ingber, the institute's 56 - year - old director, has pointed out a mattress that could prevent life - threatening sleep apnea in newborns; simulated lungs, intestines, and hearts made of silicone rubber using microchip manufacturing technology; and a machine that forces mutations in bacteria, directing their evolution so they can produce low - cost biofuels and drugIn less than five minutes, Ingber, the institute's 56 - year - old director, has pointed out a mattress that could prevent life - threatening sleep apnea in newborns; simulated lungs, intestines, and hearts made of silicone rubber using microchip manufacturing technology; and a machine that forces mutations in bacteria, directing their evolution so they can produce low - cost biofuels and drugin newborns; simulated lungs, intestines, and hearts made of silicone rubber using microchip manufacturing technology; and a machine that forces mutations in bacteria, directing their evolution so they can produce low - cost biofuels and drugin bacteria, directing their evolution so they can produce low - cost biofuels and drugs.

The goal is to find new ways to tackle the disease, which requires a thorough understanding of how the bacterium, known as Mycobacterium tuberculosis, behaves once it takes hold of the macrophages in our lungs.

Dental plaque may be the best - known example of a biofilm, but these slimy aggregates of bacteria also play major roles in such chronic infections as those in the urinary tract or in the lungs in cystic fibrosis patients.

Nontuberculous mycobacteria (NTM) include more than 150 types of bacteria, found in water and soil, that can infect the lungs when inhaled.

The bacterium that causes tuberculosis, Mycobacterium tuberculosis, or Mtb, previously was thought to infect the body only through inhalation and subsequent infection of cells in the lungs.

Gallo speculates that bacteria may be also help regulate inflammation in other areas of the body such as the lining of the lungs and nose, although different species of friendly bacteria may be responsible.

Female lung host defense cells were also better at killing this and other bacteria (Escherichia coli and Staphylococcus aureus) when tested in vitro.

The reduced numbers of bacteria and white blood cells resulted in less lung damage in the older mice who received extra vitamin E.

«Earlier studies have shown that vitamin E can help regulate the aging body's immune system, but our present research is the first study to demonstrate that dietary vitamin E regulates neutrophil entry into the lungs in mice, and so dramatically reduces inflammation, and helps fight off infection by this common type of bacteria,» said first author Elsa N. Bou Ghanem, Ph.D., postdoctoral scholar in the department of molecular biology and microbiology at Tufts University School of Medicine (TUSM).

pneumonia A lung disease in which infection by a virus or bacterium causes inflammation and tissue damage.

When you breathe in bacteria or viruses, those pathogens — or germs — stick to the mucus in your lungs.